EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Spliceosome Factor EFTUD2 Promotes IFN Anti-HBV Effect through mRNA Splicing

Pingping Hu iD, Yuwen Li iD, Wen Zhang iD, Rui Liu iD, Linya Peng iD, Ruirui Xu iD, Jinyuan Cai iD, Hui Yuan iD, Tiantong Feng iD, Anran Tian iD, Ming Yue iD, Jun Li iD und 2 weitere

Mediators of Inflammation · 2023

DOI: 10.1155/2023/2546278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, 2023. Verfasst von Pingping Hu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Janus Kinases, Spliceosomes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hainan Province Clinical Medical Center, Hainan Province Science and Technology Special Fund, Science and Technology Plan of Hainan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims. The underlying mechanisms of differential responsiveness to IFN remain poorly understood. The elongation factor Tu GTP binding domain-containing protein 2 (EFTUD2), involved in RNA splicing and pre-mRNA processing, was recognized as a novel innate immune regulator of the IFN antihepatitis C virus (HCV) effect. The aim of this study is to elucidate the mechanisms underlying EFTUD2’s involvement in IFN-mediated anti-HBV responses.

Methods

Using a CRISPR/Cas9 gene-editing system, EFTUD2 single allele knockout HepG2.2.15 cells were constructed. Subsequently, the HBV biomarkers in EFTUD2+/– HepG2.2.15 cells and wild-type (WT) cells with or without IFN-α treatment were detected. And the EFTUD2-regulated genes were then identified using mRNA sequence. Selected gene mRNA variants and their proteins were examined by qRT-PCR and Western blotting. To confirm the effects of EFTUD2 on HBV replication and IFN-stimulated gene (ISG) expression, a rescue experiment in EFTUD2+/– HepG2.2.15 cells was performed by EFTUD2 overexpression.

Results

IFN-induced anti-HBV activity was found to be restricted in EFTUD2+/– HepG2.2.15 cells. The mRNA sequence showed that EFTUD2 could regulate classical IFN and virus response genes. Mechanistically, EFTUD2 single allele knockout decreased the expression of ISG-encoded proteins, comprising Mx1, OAS1, and PKR (EIF2AK2), through mediated gene splicing. However, EFTUD2 did not affect the expression of Jak-STAT pathway genes. Furthermore, EFTUD2 overexpression could restore the attenuation of IFN anti-HBV activity and the reduction of ISG resulting from EFTUD2 single allele knockout.

Conclusion

EFTUD2, the spliceosome factor, is not IFN-inducible but is an IFN effector gene. EFTUD2 mediates IFN anti-HBV effect through regulation of gene splicing for certain ISGs, including Mx1, OAS1, and PKR. EFTUD2 does not affect IFN receptors or canonical signal transduction components. Therefore, it can be concluded that EFTUD2 regulates ISGs using a novel, nonclassical mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Janus KinasesSpliceosomesHumansHep G2 CellsHepatitis B virusRNA, MessengerSignal TransductionSTAT Transcription FactorsVirus ReplicationPeptide Elongation FactorsRibonucleoprotein, U5 Small Nuclear

Substanzen

Janus KinasesRNA, MessengerSTAT Transcription FactorsEFTUD2 protein, humanPeptide Elongation FactorsRibonucleoprotein, U5 Small Nuclear

Autor:innen und Institutionen

  • Department of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Pediatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Infectious and Tropical Diseases, The Second Affiliated Hospital of Hainan Medical University, Hainan, China.

ORCID-Profile: Pingping Hu, Yuwen Li, Wen Zhang, Rui Liu, Linya Peng, Ruirui Xu, Jinyuan Cai, Hui Yuan, Tiantong Feng, Anran Tian, Ming Yue, Jun Li, Wenting Li, Chuanlong Zhu

Förderung

  • Hainan Province Clinical Medical Center
  • Hainan Province Science and Technology Special Fund
  • Science and Technology Plan of Hainan Province
  • National Natural Science Foundation of China
  • Jiangsu Provincial Medical Key Discipline (Laboratory) Cultivation Unit

Zitieren

APA

Hu, P., Li, Y., Zhang, W., Liu, R., Peng, L., Xu, R., Cai, J., Yuan, H., Feng, T., Tian, A., Yue, M., Li, J., Li, W., & Zhu, C. (2023). The Spliceosome Factor EFTUD2 Promotes IFN Anti-HBV Effect through mRNA Splicing. Mediators of Inflammation. https://doi.org/10.1155/2023/2546278

Vancouver

Hu P, Li Y, Zhang W, Liu R, Peng L, Xu R, et al. The Spliceosome Factor EFTUD2 Promotes IFN Anti-HBV Effect through mRNA Splicing. Mediators of Inflammation. 2023. doi:10.1155/2023/2546278

BibTeX
@article{Hu2023,
  author = {Hu, Pingping and Li, Yuwen and Zhang, Wen and Liu, Rui and Peng, Linya and Xu, Ruirui and Cai, Jinyuan and Yuan, Hui and Feng, Tiantong and Tian, Anran and Yue, Ming and Li, Jun and Li, Wenting and Zhu, Chuanlong},
  title = {The Spliceosome Factor EFTUD2 Promotes IFN Anti-HBV Effect through mRNA Splicing},
  journal = {Mediators of Inflammation},
  year = {2023},
  doi = {10.1155/2023/2546278}
}
Kostenlos starten →